OLD National Bancorp IN Has $256,000 Position in Balchem Co. (NASDAQ:BCPC)

OLD National Bancorp IN cut its holdings in shares of Balchem Co. (NASDAQ:BCPC) by 4.0% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 1,457 shares of the basic materials company’s stock after selling 61 shares during the quarter. OLD National Bancorp IN’s holdings in Balchem were worth $256,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its stake in shares of Balchem by 3.8% in the first quarter. Vanguard Group Inc. now owns 3,935,935 shares of the basic materials company’s stock valued at $609,873,000 after buying an additional 144,423 shares during the period. Conestoga Capital Advisors LLC increased its position in Balchem by 2.7% during the 2nd quarter. Conestoga Capital Advisors LLC now owns 1,155,209 shares of the basic materials company’s stock valued at $177,844,000 after purchasing an additional 29,825 shares during the period. Dimensional Fund Advisors LP raised its holdings in Balchem by 0.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 697,461 shares of the basic materials company’s stock worth $107,372,000 after purchasing an additional 5,977 shares during the last quarter. Bank of New York Mellon Corp lifted its position in shares of Balchem by 1.2% in the 2nd quarter. Bank of New York Mellon Corp now owns 277,475 shares of the basic materials company’s stock worth $42,717,000 after purchasing an additional 3,279 shares during the period. Finally, William Blair Investment Management LLC boosted its stake in shares of Balchem by 8.4% in the 2nd quarter. William Blair Investment Management LLC now owns 233,831 shares of the basic materials company’s stock valued at $35,998,000 after purchasing an additional 18,104 shares during the last quarter. 87.91% of the stock is owned by institutional investors.

Balchem Price Performance

Balchem stock opened at $166.76 on Thursday. The stock’s 50 day moving average price is $171.60 and its two-hundred day moving average price is $162.09. The stock has a market capitalization of $5.41 billion, a price-to-earnings ratio of 47.11, a PEG ratio of 5.43 and a beta of 0.65. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.79 and a current ratio of 2.83. Balchem Co. has a 52-week low of $110.74 and a 52-week high of $186.03.

Balchem (NASDAQ:BCPC) last posted its quarterly earnings results on Friday, July 26th. The basic materials company reported $0.98 EPS for the quarter, topping analysts’ consensus estimates of $0.95 by $0.03. Balchem had a net margin of 12.52% and a return on equity of 10.94%. The business had revenue of $234.08 million during the quarter, compared to analysts’ expectations of $241.26 million. On average, equities analysts predict that Balchem Co. will post 3.96 earnings per share for the current year.

Insider Activity

In other Balchem news, SVP Gunsteren Job Leonard Van sold 7,750 shares of the stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $180.05, for a total value of $1,395,387.50. Following the transaction, the senior vice president now owns 8,540 shares in the company, valued at approximately $1,537,627. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.25% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. HC Wainwright lifted their target price on shares of Balchem from $170.00 to $185.00 and gave the stock a “buy” rating in a research note on Wednesday, July 31st. StockNews.com lowered Balchem from a “buy” rating to a “hold” rating in a research report on Monday, July 29th.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.